Poseida promotes cell therapy president to CEO; After IPO, Neumora appoints R&D chief
→ The CEO post is changing hands once again at Poseida, as Kristin Yarema gets promoted to the top spot on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
